Patients with severe hypertriglyceridemia (sHTG) achieved an 83% median reduction in triglycerides (TG), with 96% of patients achieving TG levels below 500 mg/dL, a threshold associated with increased ...
WHEAT RIDGE, CO / ACCESS Newswire / March 27, 2026 / Lifeloc Technologies, Inc. (OTC:LCTC), a global leader in the ...
Acquisition integrates patent-pending algorithms and data insight engine into PetaSight’s operating system so pharmaceutical ...
Demands Openness to Evaluating Credible Opportunities to Maximize Shareholder ValueUnderscores the Company’s Sustained Value Destruction, Lack of Permanent Leadership, and Board’s Poor Alignment with ...
One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety profile in a once daily pill for moderate-to-severe plaque psoriasisResults ...
Customer-first initiative helps specialty pharmacies and e-commerce leaders keep pace with the rapidly evolving GLP-1 ...
Market OverviewThe global MedTech Contract Manufacturing Organization (CMO) market is witnessing robust growth, expanding at ...
Homecare Feeding, Aging Population, and Technological Innovation Driving Global GrowthThe nasogastric intubation market is ...
March 26, 2026] A new report from Phacilitate argues that the biggest threat to cell and gene therapy (CGT) expansion is no ...
Completes Strategic Transformation into an Immunotherapy Company and Continues to Advance Entolimod Platform Toward Potential ...
For global buyers, the evolution of Chinese innovative drugs is no longer merely about “more choices” — it has become a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results